Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2200995 | Neurochemistry International | 2010 | 7 Pages |
This study investigated the effect of geldanamycin post-treatment on the development of secondary brain injury and neurological deficits in a mouse model of intracerebral hemorrhage. CD-1 mice received stereotactic injection of collagenase type VII into the right basal ganglia. Treatment groups were administered 1 mg/kg (low dose) or 10 mg/kg (high dose) of geldanamycin. Mice were euthanized at two time-points: 24 h or 72 h. Blood–brain-barrier permeability, brain edema, and neurobehavioral deficits were assessed. Additionally, the effects of geldanamycin on heat shock protein 27 and 72; tumor necrosis factor-alpha and interleukin 1 beta expressions were evaluated.High dose geldanamycin significantly attenuated blood–brain barrier disruption and brain edema after intracerebral hemorrhage. Neurobehavioral outcomes were significantly improved in some parameters by high dose treatment. Molecular results showed a marked increase in heat shock protein 72 expression in ipsilateral brain of geldanamycin treated groups with a reduction in the pro-inflammatory tumor necrosis factor-alpha.ConclusionGeldanamycin post-treatment is neuroprotective in the mouse model of intracerebral hemorrhage. Geldanamycin administration results in reduction of inflammation, preservation of blood–brain-barrier and amelioration of neurobehavioral deficits after an insult possibly by upregulation of heat shock protein 72.
Research highlights▶ Intracerebral hemorrhage is a deadly disease and without a cure. ▶ Geldanamycin upregulated heat shock proteins 27 and 70 and provided neuroprotection in ischemic animal models. ▶ This study investigated the effect of geldanamycin treatment on the development of secondary brain injury and neurological deficits in a mouse model of intracerebral hemorrhage. ▶ Geldanamycin significantly attenuated blood–brain barrier disruption and brain edema after intracerebral hemorrhage and improved neurobehavioral functions. ▶ Geldanamycin increased heat shock protein 72 expression in ipsilateral brain and reduced pro-inflammatory tumor necrosis factor-alpha.